Signal AI

Archives
Log in
Subscribe
March 24, 2026

Signal AI Tuesday: Finance, Biotech, Marketing, Public Sector & Healthcare

Signal AI Tuesday — March 24, 2026

Your weekly pulse on AI across industries.


🏦 Finance

Agentic AI is reshaping banking — AI agents drove $262 billion in holiday sales, pushing banks toward "agent-facing" technologies for embedded lending. 71% of banks have deployed gen-AI, with strong results in fraud detection and risk scoring. The focus now: ROI discipline, vendor consolidation, and making credit products AI-readable via APIs.

Key insight: Banks must partner with fintechs or risk invisibility in AI-driven commerce.


🧬 Biotech

AI biotechs are hitting clinical milestones. Earendil Labs raised $787M for its AI biologics platform, with a Phase 2-ready antibody (HXH-1001). Iambic Therapeutics landed a $1.7B Takeda partnership for AI-driven small molecule discovery. NVIDIA GTC showcased agentic AI accelerating protein design — 1.7 million new protein complexes added to AlphaFold.

New legislation (AI-Ready Bio-Data Standards Act) aims to standardize biological data for AI drug discovery.


📢 Marketing

AI ad spend projected to surge 63% to $57B in the US. The Trade Desk is beta-testing Claude for programmatic campaign creation. Anthropic runs global marketing with a single AI-augmented operator. Google explores ads embedded directly in Gemini AI responses.

Agentic AI tools are cutting media costs 80%+ in early tests — but CFOs are driving adoption over CMOs due to cost pressures.


🏛️ Public Sector

The White House released a National AI Policy Framework (March 20) aiming to promote US AI dominance while preempting state-level AI laws. Key moves: streamlining data center permits, establishing regulatory sandboxes, and mandating "American AI Systems" in federal contracts.

States are active: Idaho passed generative AI in education (SB 1227), California requires annual reports on automated decision systems, and Oregon approved AI chatbot safety rules.


🏥 Healthcare

Clinical validation is accelerating. A Chinese trial across 77 hospitals showed an AI stroke decision support system improved care quality and reduced recurrent vascular events. Children's National Hospital launched a pediatric AI research division.

Funding: Verily raised $300M for precision medicine platforms. Consumer adoption is surging — one in three US adults now use AI chatbots for health questions.

But trust issues persist: AI-denied Medicare Advantage claims are overturned 75% on appeal.


Signal AI Tuesday — Curated AI industry intelligence, delivered weekly.

Don't miss what's next. Subscribe to Signal AI:
Powered by Buttondown, the easiest way to start and grow your newsletter.